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Interferon-')' (IFN-y) is a pleiotropic cytokine that 
modulates type I collagen synthesis. In addition, 
IFN-y also exerts potent effects on cellular trypto-
phan levels by inducing the expression of indole-
amine 2,3-dioxygenase (IDO) and tryptophanyl-
tRNA synthetase. Because recent evidence indicates 
that !DO-mediated oxidative tryptophan catabolism 
is important in cellular responses to IFN-y, we inves-
tigated the role of IDO in the IFN-y-induced modu-
lation of type I collagen gene expression. IFN-'Y (;:::so 
U/ml) stimulated IDO expression in human dermal 
fibroblasts in vitro, resulting in a > 90% depletion of 
tryptophan in the culture media following incubation 
for 48 h . Higher concentrations ofiFN-y (;:::;500 U/ml) 
caused a marked decrease in type I collagen mRNA 
levels. Time-course studies indicated that maximal 
induction ofiDO mRNA expression in IFN-y-treated 
fibroblast cultures (24 h) preceded the maximal de-
crease in collagen mRNA (96 h). Type I collagen 
mRNA levels were also markedly and selectively 
I nterferons are multifunctional cytokines that induce an antiviral state, inhibit the growth of certain tumor cells and intracellular pathogens, and activate the ell.lJression of a set of ceiJular genes iJ1 many ceiJ types both in vitro and in vi11o [1] . lnterferon-y (IFN-y) , a product of activated T lympho-
cytes, macrophages, and natural killer cells, stimu lates the produc-
tion of indoleamine 2,3-dioxygenase (IDO), tryptophanyl-tRNA 
synthetase, nitric oxide SY11thetase, and other proteins of unknown 
function [2-4]. These gene products mediate many of the impor-
tant biologic activities associated with lFN-y [5]. Recent studies 
indicate that induction of cellular IDO, the enzyme that catalyzes 
the oxidation of tryptophan to N- formylkynurenine [ 6], represents 
an important mechanism contributing to the inhibitory effects of 
lFN-y on the growth of some tumor cells [7,8] . Similarly, induction 
of fDO by IFN-y in a variety of host ceiJs has been implicated in the 
inhibition of the intracellular replication of parasites such as Toxo-
plasma gondii and C hlamydia psittaci [9-11] . We have recently shown 
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decreased in fibroblasts maintained in tryptophan-
depleted cultures. Addition of exogenous tryptophan 
(up to 2500 p,M) to IFN-y-treated fibroblasts restored 
"normal" concentrations of tryptophan in the cul-
ture media, but did not abrogate the IFN-y-induced 
decrease in collagen mRNA. Addition of the trypto-
phan metabolite kynurenine, in concentrations sim-
ilar to those generated in fibroblast cultures follow-
ing IFN-y treatment for 48 h, had no significant effect 
on type I collagen mRNA levels. These results indi-
cate that although IFN-y causes activation of IDO 
and enhanced tryptophan catabolism in fibroblast 
cultures, neither the ensuing tryptophan starvation 
nor the accumulation of kynurenine in the culture 
media can fully account for the inhibitory effects of 
IFN-y on type I collagen mRNA expression. Key 
words: extracellltlar matrixl.fil~rosislcytokines/getre regula-
tionlitrdoleam.itre 2,3-dioxygenase. ] Invest Dermatol 105: 
388-393, 1995 
that abrogation of interleukin-1j3 (IL-1/3)- induced expression of 
collagenase aJld stromelysin by IFN- ")1 in cultured dem1al fibrob lasts 
was mediated through depletion of tryptophan, aJ1d could be 
overcome by the addition of exogenous tryptophan to the cultures 
[12]. These studies suggest that modulation of cellular tryptophan 
metabolism plays a crucial role in mediating certain ceiJular re-
sponses to lFN-y. 
In addition to the roles in immune responses, IFN-y exerts 
potent effects on coiJagen production. In 11itro, IFN-y inhibits the 
synthesis of types I and TI collagens [13-16] aJ1d abrogates the 
stimulatory effects of transforming growth factor-J3 on coiJagen 
synthesis in fibroblasts [17,18]. Therefore, IFN-y may have a 
physiologic role as well as important therapeutic potential in 
preventing excessive collagen accumulation during tissue repair in 
the skin. The mechanisms whereby IFN-y causes inhibition of 
coiJagen gene expression require elucidation. In the present study, 
we examined whether induction of lDO expression and tryptophan 
catabolism in cultured dermal fibroblasts played a role in the 
modulation of type I coUagen mRNA expression by IFN-y i11 vitro . 
The results indicate that IFN-y caused a decrease in type I coiJagen 
mRNA levels and a marked in crease in lDO mR.NA levels. 
Increased IDO expression was associated with enhanced trypto-
phan degradation, resulting in depletion of this amino acid from the 
culture media and a corresponding rise in concentrations ofkynure-
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nine. The levels of type I collagen mRNA were markedly reduced 
in fibrobla sts cultured in tryptophan-deple ted media. However, 
repletion of tryptophan in IFN-')'-treated cultures failed to prevent 
the decrease in type I collagen mRNA. Therefore, the inhibitory 
e ffects oflFN-')' on type I collagen mRNA expression in fibrob lasts 
appear to be m ediated primarily by m echanisms independent from 
induction of IDO gene expression and consequent depletion of 
tryptophan and accumulation of kynurenine . 
MA TER.IALS AND METHODS 
Materials AU tissue-culture reagents were obtained from Gibco (Grand 
Island, NY) . L-tryptophan and kynurenine (purity approximately 99%), and 
cycloheximide were obtained from Sigma Chemical Co. (St. Louis, MO) . 
Diiferent batches ofL-tryptopha.n used in these experiments gave consistent 
and reproducible results. R ecombinant humaniFN--y was from Boehringer-
Mannheim (Indianapolis, IN) . 
Fibroblast Cultures Cell lines used in the present experiments were 
established from foreann skin biopsies of six healthy adults by explant 
, teclmiques previously described [1 9]. Cells were seeded into 75-cm2 
tissue-culture A asks containing modifiep Eagle 's medium (MEM) , 1% 
vit~mins and 2 mM L-glutamine, supplemented with 5% fetal bovine serum 
(FBS). When the cells reached visual confluence, fresh medium with or 
without ascorbic acid (50 p,g/ml), and 5% FBS (extensively dialyzed against 
0.05 M Tris, pH 7.5 , 0.15 M NaCl to remove free amino acids) were added 
to the cultures. In selected experiments, tryptophan-free MEM (Select-
Anline, Gibco) was used. Cellular toxicity was evaluated at the end of the 
incubation period by trypan blue staining, and release of LDH into the 
media, as desc1·ibed previously [20) . 
Analysis of RNA Total RNA was extracted from confluent fibroblasts 
u sing the CsCI centrifuga tion method, and subjected to Northern analysis 
[21). Hybridizations were perfonned with cD NAs previously labeled with 
[cx-32P]dCTP to a specific activity at least 1 X 108 cpm/ p,g by nick 
translation. Autoradiograms were analyzed by scanning at the Linear range 
of the absorbance curve with a laser densitometer (LKB, Bromm a, Sweden). 
The following cDNAs were used: human type I collagen (22] , HLA-DR Cl 
chain [23) , fibronectin (24), and rat glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) [25) , all obtained from the American Type Culture 
Collection (Rockville, MD) ; and human !DO, a gift of DrS. Gupta (Hipple 
Cancer Center, Dayton, OH) [26]. 
Determination of Tryptophan and Kynurenine Concentrations 
Total free tryptophan and kynurenine were assayed by high-performance 
liquid chromatography on a C-18 column eluted isocratically using a solvent 
of phosphate buffer (0 .1 M) , adjusted to pH 3.6 with sodium hydroxide, and 
containing 0.001 M disodium- etbylenediaminetctraace tic acid and 5% 
acetonitrile. Samples of culture media were deprotcinizcd 'vith perchloric 
acid (0.6 M) . Tryptophan was detected by its native Huorescence (activation 
at 290 nm and emission at 360 nm) using a Hewlett-Packard model 
HPl 046A programmable Huorimetcr. Kynurenine was detected in the same 
chromatograms by ultraviolet absorbtion at 360 nm using a R.ai.nin UV- 1. 
ab sorbance detector in series with the fluorimeter. Chromatogram record-
ings and calculations were done using the Rainin Dynamax program 
(R.ainio Instrument Co., Woburn MA) . 
RESULTS 
IFN-1' Modulates Type I Collagen mRNA Expression and 
Tryptophan Metabolism in Fibroblast Cultures To examine 
the effect of IFN-')' on collagen mRNA levels, IFN-y (500 U/mJ) 
was added to confluent fibroblasts . Afte r various lengths of incu-
bation, cultures were harvested and mR.NA w e re examined by 
Northern analysis. Exposure of the cultures to IFN-')' for up to 8 h 
was not associated with detectable changes in type I collagen 
mRNA (data not shown). However, incubation with IFN-')' for 
24 h caused a greater than 50% decrease in type l collagen mRNA 
levels, with m aximal (> 90%) inhibition at 96 h (Fig 1A). 
To de termine whether inhibition of collagen mR.NA expression 
by IFN-')' was re lated to modulation of tryptophan m etabolism, we 
measured IDO mRNA levels in untrea ted and in IFN-y-treated 
fibroblasts. !DO mRNA was undetectable in untreated fibrob lasts 
(Fig 1B). Exposure to IFN-y (500 U / ml) for as little as 3 h caused 
a small but detectable increase in !DO mRNA that peaked at 24 h. 
A single transcript with an apparent molecular size of 2.2 kb was 
observed. T he stimulation of IDO mRNA by IFN-')' was dose 
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dependent, with maximal effect at at least 50 U/ml IFN-')'; in 
contrast, maximal inhibition of collagen m.RNA required a t least 
500 U / ml (data not shown) . 
T he product of tryptophan oxidation by IDO is fom1ylkynure-
nine, which in most cells is further catabolized by kynurenine 
fonnidase to produce kynurenine [27). To examine the effects of 
IFN-')' on tryptophan m etabolism in dermal fibroblasts, culture 
supernatants from fibroblasts exposed to IFN-')' for various periods 
were ana lyzed for tryptophan and kynurenine concentrations. 
Tryptophan concentrations in m e dia of fibroblasts not exposed to 
IFN-')' remained unchanged fo llowing a 96-h incubation, and the 
cells produced no kynurenine (data not shown). Exposure of 
fibroblasts to IFN-')' (500 U / ml) caused a time-dependent > 95% 
decrease in tryptophan and a greater than twentyfold increase in 
k ynurenine concentrations (Fig 1B). These findings indicate that 
IFN-')' induced the expression of IDO, resulting in markedly 
enhanced degradation of tryptophan and consequ ent depletion of 
tllis essential amino acid from the culture media and a correspond-
ing accumulation of kynurenine . 
To examine the role of protein synthesis in modulation of type I 
collagen and IDO gene expression by IFN-y, some cu,Jtures were 
pretreated with cycloheximide (10 !J.g/ ml) 2 h prior to acJdition of 
IFN-')' (1000 U/ml) , and mRNA amow1ts w~re Q!')term.ined fol-
lowing a furth er 72-h incubation. As shown in Fig ~ · cyclohexi-
mide almost completely prevented the inhibitjop qft:rP-tr ~ ~ollagen 
mRNA expression; in contrast, the induction of IDO mRNA by 
IFN-')' appeared to be only moderate ly decreased at 72 h. These 
results suggest that IDO mRNA u1duction in IFN-y-treated fibro-
blasts may be a primary response, whereas tl1e delayed inhibition of 
type I collagen mRNA expression requires de Il OilO protein synthe-
sis. 
Tryptophan Depletion Inhibits Type I Collagen mRNA 
Expression To examine the influence of tryptophan concentra-
tion on type I collagen mRNA expression, some fibroblasts were 
switched from complete media (containing 50 !J.M tryptophan, as 
indicated by the manufacture r) to tryptophan-depleted m edia and 
dialyzed (tl1ere fore tryptophan-depleted) FBS at confluence. Mter 
48 h , some of the cultures received exogenous tryptophan for an 
additional 24 h of u1Cubation. No differences in viability or total 
protein synthesis between fibrob lasts cultured in tryptophan-de-
pl eted or tryptophan-containing m edia were detected a t the end of 
the in cubation period (data not shown). Northern analysis of total 
RNA indicated that type T collagen mRNA levels were m arkedly 
redu ced in cultures maintain ed under tryptophan-free conditions 
(Fig 3). ln contrast, mRNA levels for fibronecti.n , a m~or fibro-
blast product, o r GAPDH, a " housekeepu1g enzyme," remained 
unchanged il1 tryptophan-depleted fibroblasts, u1dicating tl1e lack 
of significant cellular toxicity under these conditions . 
Tryptophan Supplementation of IFN-y-Treated Cultures 
Fails to Abrogate Inhibition of Type I Collagen mRNA 
Expression Because IFN-')' induced the d egradation of trypto-
phan in the culture media, and fibroblasts under tryptophan-free 
conditions displayed reduced collagen mRNA levels, we speculated 
that inllibition of collagen mRN A expression by IFN-')' w as caused 
by tryptophan depletion. To test this hypothesis, we examined 
whether addition of exogenous tryptoph an to IFN-y-treated (and 
tl1erefore tryptophan-depleted) cultures would restore basal ex-
pression of type I collagen mRNA. For this purpose, IFN-')' was 
added to confluent fibroblasts maintained in complete m edia and 
was then fo llowed by various concentra tions of tryptophan. Inc u-
bation was contu1ued for a further 28 h . At the end of the 
experiment, m edia w ere harvested and the concentrations of 
tryptophan determined . As shown u1 Table I , addition of exoge-
nous tryptophan to the IFN-y-trea ted fibroblast cultures resulted 
fo llowing a 28-h u1cubation u1 con centrations that exceeded those 
in untreated cul tures. Total RNA was harvested at the end of the 
experiments and subjected to Nortl1em analysis. As shown u1 Fig 4 , 
addition of tryptophan in concentrations sufficient to exceed nor-
mal levels to th e IFN-y-treated culture's f.Liled to prevent the 
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Figure 1. Interfero·n-y modulates collagen and indole amine 2,3 -dioxygenase (IDO) gene expression in dermal fibroblasts . Confluent cultures 
of normal human skin fibrobla sts were incubated w·ith interferon-")' (JFN--y, 500 U / ml) fo r various periods. At the indicated times, total RNA was isolated, 
and steady-state mR.NA levels were determined by Northern hybridization (1 0 p.g/lane) to [32P]- labeled (A ) type I collagen and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) cDN As, or (B) IDO eDNA, as described in M aterials <md Methods. Abundance ofm.RNA was quantita ted by scanning densitometry 
of the autoradiograms, and the values are shown after correction for varia tions in GAPDH mRNA levels (A , bo11o111). R.esults represent the mean from two 
separate experiments. B. Modulation of lDO gene expression . Confluent cultures were exposed to IFN--y for various periods as described above. At the end 
of the incubation period, cellular IDO mR.NA levels (upper panels), and tryptophan and kynurenine in the culture media (lower Jlflllels) were quantitated, as 
described in Materials and Methods. 
fFN-y- induced decrease in type I col.lagen mRNA. As pre viously 
reported [23,27] , treatment with lFN-y markedly increased IDO 
and HLA-DR mRNA, which w as unaffected by the concentration 
of tryptophan in these cultures. 
Tryptophan Metabolites Do Not Influence Type I Collagen 
mRNA Expression Confluent human fibroblasts exposed to 
IFN-y (500 U/ml) for 48 h in complete m edia ;,, vitro produce - 15 
J.LM kynurenine, the principal tryptophan metabolite (Fig 1B). To 
examine the possibility that decrease in type I collagen mRNA in 
IFN-y--trea ted fibroblasts was due to direct inhibition of collagen 
gene expression by tryptophan mddation produ cts, w e examined 
the influence of kynurenine on fibroblast collagen synthesis. As 
shown in Table II, addition of kynurenine to confluent fibrobl as ts, 
in con centrations similar to or exceeding those attained in IFN-y-
treated fibrob last cultures, did not result in a significant change in 
type I collagen mRNA levels . These fmdings indicate that accu-
mulation of kynurenine in the culture m edia following treatment 
with IFN-y cannot account for the decrease in collagen mRNA 
expression. 
DISCUSSION 
The present results indica te that in human dermal fibroblasts, 
IFN-y caused a tin1e-dependent decrease in type I collage n mRNA, 
with a marked increase in IDO mRNA and enzyme actiVIty. 
Consistent with results from a recent study [28], the inhibition of 
collagen gene expression, but not the induction of IDO gene 
expression , w as sensitive to cyclohexim ide . Induction of IDO 
expression occurred m o re rapidly and at lower concentrations of 
IFN-y than inhi bition of collagen gene expression . IFN-y, a key 
mediator of inflammati on , induces several enzymes involved in 
tumoricidal and antimicrobial activities of target cells [29]. The 
m echanisms involved in many of these cellu lar responses have 
recently been illuminated. lt has been shown that binding by IFN-y 
to distinct surface receptors is followed by activation of the JAK 
family of intracellu lar ty rosine kinases [30]. Tlus leads to activation 
of cytoplasnuc proteins tha t translocate into the nucleus and bind to 
recognition sequen ces in th e regulatory regions of certain IFN- y--
inducible genes [31]. Evidence has been presented indicating that 
IFN-y-induced !DO transcription is mediated through IFN- y--
responsive elements in the 5' flanking region of the IDO gen e [2] . 
The modulation of other cellular genes by IFN-y appears to 
proceed through indirect mechanisms involving , for example, the 
activation of cell ular arginine metabolism 11ia nitr ic m.:ide syn-
thetase , or the activation of tryptophan metabolism Pia !DO [4 ,11 ]. 
In the present studies, lFN-y caused a virtually comple te depletion 
of tryptophan and a parallel increase in kynnrenine in the culture 
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Figure 2. Cycloheximide prevents the inhibition of collagen, bnt 
not induction of IDO mRNA by IFN- y. Cycloheximjde (CHX, 1 0 
J.Lg/ml) was added to confluent fibroblasts maintained in complete media, 
followed 2 h later by IFN-y (1000 U/ m1). At the end of an add itional 70 h 
incubation, cultures were harvested. RNA was analyzed by Northern 
hybridization with type I collagen, IDO, and GAPDH eDNA. 
media, indicating a marked enh<U1Cement of tryptophan catabolism 
in the dermal fibroblasts. Because changes in intracellular trypto-
phan concentration follow closely the changes in the extracellular 
pool in IFN-y-treated fibroblasts [32), the findings suggest that 
IFN- ')' induced tryptophan deprivation of these cells. 
Because the inhibitory effects ofiFN-y on type I coll agenmRNA 
expression were associated with induction of IDO and resultant 
tryptophan catabolism, we speculated that depletion of tryptophan 
in the cultures may have inte rfered with basal collagen gene 
expression . Indeed, fibroblasts cultured in tryptophan-depleted 
media displayed markedly reduced type I collagen mRNA levels , 
whereas fibronect:in mRNA levels w e re not altered. The mecha-
nism whereby tryptophan deprivation of fibroblasts selective ly 
interferes with their express ion of type I co ll agen mRNA is 
unknown. Tryptophan may be required for the synthesis or DNA-
binding activity of nuclear transcription factors mediating the basal 
activity of type I collagen gene. Indeed, conserved tryptophans 
("tryptophan cluste rs") have been shown to be n ecessary for 
sequence-specific DNA binding activity of the c-myb proto-onco-
gene [33]. Therefore, we examined whether repletion of trypto-
phan in cultures rendered depleted of tryptophan by prolonged 
incubation with IFN-y could "restore" normal type I collagen 
mRNA levels. The results showed that addition of tryptophan, in 
amo unts sufficient to achieve greater than control concentrations at 
the end of the incubation period, to fibroblasts pre-treated with 
IFN-y failed to reverse the inhibitory effects of IF.N-y. 
Taken together, these observations indicate that although tryp-
tophan appears to be required for basal expression of the type I 
collagen gene in dermal fibroblasts, tl')rptophan degradation is not 
directly involved in inhibition of coHagen mRNA expression by 
IFN-y. Tryptophan, an essential am.i.no acid, is required for protein 
synthesis and serves as a precursor for biologically important an1ines 
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Figure 3. Tryptophan depletion down-regulates collagen mRNA 
levels. Confluent fibroblasts were maintained in complete MEM, then 
washed extensively in PBS and switched to tryptophan-free MEM and 5% 
FBS (/niles 2-4), or returned to complete MEM (/a,c 1), at confluence. After 
48 h, tryptophan (0.5 or 5 J.LM) was added to cultures. as indjcated . At the 
end of an additional 24 h incubation, cultures were harvested. RNA was 
analyzed by Northern hybridization with type I co llagen, fibronectin , and 
GAPDJ-1 eDNA (top). Collagen mR.NA abundance was quantitated, and the 
values (mean of two separate experiments) are shown after cotTection for 
variations in GAPDH mRNA levels (bottom). 
[34]. Furthermore, tryptophan metabolites m ay function as power-
ful anti-oxidants [35]. We recently reported that in supraphys.i-
ologic concentrations tryptophan, but not other amino acids, 
caused marked stimuh1tion of collage n ase gene expression in 
de rmal fibroblasts i11 vitro [20]. In contrast, IFN-y--induced deple-
tion of tryptophm1 in fibroblast cultures effective ly prevented the 
stimulation of collagenase express ion by IL- l [12]. Because tryp-
tophan appears to be important in the regulation of several biologic 
processes, its degradation and ensuing cellular starvation may have 
pleiotropic effects. 
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Table I. Effect of the Addition of Tryptophan to IFN-y-
Treated Dermal Fibroblast Cultures on Tryptophan 
Concentration in the Culture Media" 
Concentration of 
Tryptophan Added 
(J.Lg/ml) 
Control'' 
0 
100 
500 
Final Concentration 
ofTryptophan (J.LM) 
31 
5 
127 
1151 
'' Tryptophan was added to confluent fibrob lasts that had been pre-incubated with 
IFN-y (500 U/ml) in complete media. At the end of the incubation (28 h) , rnedia were 
harvested, and tryptophan concentrations were determined as described in Matcrial.f aud 
Nlellwds. The values shown re present the mean of two scpamtc experiments. 
1
' Contro l cul tures received neither IFN-y nor exogenous tryptopha11 . 
Table II. Tryptophan Metabolite Kynurenine Does Not 
Affect Type I Collagen mRNA Levels or Viability of 
Dermal Fibroblasts In Vitro" 
Kynurenine Relative m.R.NA Cell Viability' 
(J.LM) level1' (%) 
0 4 .99 88 
100 5.44 90 
250 5.33 94 
500 5.43 87 
1
' Kynurenine was added to confluent cultures of fibrobla sts maintained in complete 
m edia . C ultures were harvested following a 48-h incubation period. and type I 
coHagen mRNA levels were dctennincd by Northern analysis, as described in Materia ls 
nud Metftods. 
1
' R elative levels of l)'pe I collagen mRNA, exp ressed as densitometric units. 
corrected for variations in GAPO H rnllNA levels in the same samples. 
r Viability was determined by counting ce lls in :1 hemocytometer~ and assessing 
trypan blue dye exclusion. 
T he present findings indicate that tryptophan deple tion results in 
a marked and selective decrease in type I collagen mR.N A expres-
sion in culture d fibroblasts. T he results suggest, however·, that 
induction of oxidative tryptophan catabolism and ensuin g trypto-
phan depletion are not directly responsible for the decrease in type 
I collagen mRNA in l FN- ')'-treated fibroblasts . The e ffects of 
IFN-')' on collagen gene expression may b e direct; ind eed, several 
IFN-')'-response e lements (TTnCmmAA) are located in the up-
stream regulatory region of the human COL1A1 gene (unpub-
lished). Alternately, intracel.lular pathways distinct from tryptophan 
catabolism, such as indu cible nitric oxide production, may b e 
involved in mediating the effects of l FN-')' on type I collagen gene 
expression . In this r egard, it is of g reat interest that recent 
observations indicate a complex functional interrelationship b e-
tween arginine and tryptophan catabolism , two important IFN--y-
inducible cellular pathways [36,37]. T he relative ly d e layed inhibi-
tion of type I collagen mRNA expression fol.lowing exposure of 
fibroblasts to IFN-')', and the sensitivity of this response to cyclo-
h eximide, suggest that the effect of IFN-')' is a secondary phenom-
en o n. A precise understanding of the molecular mechanisms 
through ,w hic h IFN-')' inhibits coll agen pro duction. in dermal 
fibroblasts may facilitate the application of IFN-')' in anti-fibrotic 
therapy. 
f,fl'c tlwuk Dr. S. C uptn for gcuerously pro11irliug the fD O eDNA used i11 these 
experiweuts, Dr. R. Heilll erfor criticnl w•icll' of tl1e lllfl/1/lscript, nurl R.A. A re11rl for 
help with tl1 e tryptophmJ/ky11ureui11e assays. T his study 11•ns s11ppo1ted by Natimwl 
f11 stitutes of Hen /t./1 grn11ts AR-42309 n11d AR-01817, n11d by a rcsearc/1 grn11t fm w 
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Figure 4. Repletion of tryptophan in the cultures fails to abrogate 
inhibition of collagen mRNA expression in IFN-y-treated fibro-
blasts. lFN-')' (500 U/ml) was added to fibroblasts maintained in complete 
media, followed 8 h later by various amounts of tryptophan, as indicated. At 
the end of an additional 28 h incubation, cultures were harvested, and RNA 
was analyzed by Northern hybridization with type ·1 collagen. HLA-DR 
alpha chain (DR) , IDO, and GAPDH eDNA, as described in Mnterinls mrd 
Metlwds. Abundance of mR.NA was quantitated, and the va lues are shown 
after correction for variations in GAPDH mR.NA levels (lower panels) . 
Values shown represent the mean of results from two separate experiments . 
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